Lupus clinical characteristics |
Disease duration | 9.4±6.4 |
Age at diagnosis | 22.6±9.1 |
SLE Disease Activity Index | 4.6±3.5 |
SLICC | 0.7 (0.2-1.2) |
Anti-dsDNA antibodies (mg/dL) | 123.7±106.3 |
C3 complement (mg/dL) | 104.7±37.4 |
C4 complement (mg/dL) | 24.3±13.8 |
Urine creatinine (mg/dL) | 184 (132-236) |
Urine protein (mg/dL) | 123 (85-161) |
Urine protein/creatinine ratio | 0.5 (0.2-0.7) |
White blood cell count | 4.9 (3.9-5.9) |
Medications |
Hydroxychloroquine | 17 (68%) |
Azathioprine | 6 (24%) |
Methotrexate | 1 (4%) |
Humira | 1 (4%) |
Benlysta | 1 (4%) |
Mycophenalate mofetil | 10 (40%) |
Prednisone | 19 (76%) |
General history |
Body mass index | 26±5 |
Blood pressure | |
Systolic (mmHg) | 121 (±18) |
Diastolic (mmHg) | 73 (±14) |